Telix Pharmaceuticals Limited (ASX: TLX)

Telix Pharmaceuticals Ratios and Metrics

Market cap in millions AUD. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Nov 20, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	7,430	3,263	2,300	2,209	1,060	393
Market Cap Growth	74.40%	41.89%	4.10%	108.44%	169.99%	176.59%
Enterprise Value	7,333	3,145	2,180	2,161	1,039	384
Last Close Price	22.20	10.08	7.27	7.75	3.78	1.55
PE Ratio	150.93	626.09	-	-	-	-
Forward PE	87.37	32.83	-	-	-	-
PS Ratio	11.15	6.49	14.37	290.85	203.32	112.65
PB Ratio	18.37	21.91	28.75	1023.78	13.41	5.60
P/TBV Ratio	1387.98	83.14	109.40	-	53.46	13.95
P/FCF Ratio	193.76	229.72	-	-	619.12	-
P/OCF Ratio	125.41	136.63	-	-	540.78	-
EV/Sales Ratio	11.36	6.26	13.62	284.54	199.24	110.26
EV/EBITDA Ratio	98.30	55.00	-	-	-	-
EV/EBIT Ratio	108.88	60.60	-	-	-	-
EV/FCF Ratio	191.23	221.37	-	-	606.68	-
Debt / Equity Ratio	0.05	0.12	0.13	1.18	0.03	0.03
Debt / EBITDA Ratio	0.30	0.30	-	-	-	-
Debt / FCF Ratio	0.58	1.23	-	-	1.29	-
Asset Turnover	1.22	1.54	0.88	0.06	0.04	0.04
Inventory Turnover	11.07	14.59	10.92	1.25	3.45	4.29
Quick Ratio	0.81	1.24	1.90	1.13	4.62	5.42
Current Ratio	0.99	1.43	2.02	1.25	4.69	5.52
Return on Equity (ROE)	20.49%	4.55%	-253.34%	-198.36%	-60.21%	-45.32%
Return on Assets (ROA)	7.97%	9.92%	-25.37%	-37.95%	-23.64%	-28.06%
Return on Capital (ROIC)	16.34%	25.26%	-97.35%	-118.20%	-40.13%	-39.67%
Earnings Yield	0.66%	0.16%	-4.53%	-3.64%	-4.23%	-7.10%
FCF Yield	0.52%	0.44%	-3.09%	-2.75%	0.16%	-6.05%
Buyback Yield / Dilution	-5.90%	-4.21%	-10.08%	-9.69%	-10.21%	-15.49%
Total Shareholder Return	-5.90%	-4.21%	-10.08%	-9.69%	-10.21%	-15.49%

Source: S&P Capital IQ. Standard template. Financial Sources.